Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.135
Peer-review started: October 3, 2014
First decision: November 4, 2014
Revised: January 27, 2015
Accepted: March 18, 2015
Article in press: March 20, 2015
Published online: July 28, 2015
Processing time: 305 Days and 18.8 Hours
In this review, we report on the use of indwelling pleural catheters in the treatment of malignant pleural effusions. We describe the most commonly used catheter. Also, treatment with indwelling pleural catheters as compared to talc pleurodesis is reviewed. A comparison of efficacy, costs, effects on quality of life, and complications is made. Only one randomized controlled trial comparing the two is available up to date, but several are underway. We conclude that treatment for malignant pleural effusions with indwelling pleural catheters is a save, cost-effective, and patient-friendly method, with low complication rates.
Core tip: Indwelling pleural catheters appear to be as efficient and cost-effective as talc pleurodesis in the treatment of malignant pleural effusions with a low complications rate. A great advantage is that terminally ill patients can be treated at home in the last stage of their lives.